| Carbon monoxide poisoning LW Kao, KA Nañagas Emergency Medicine Clinics 22 (4), 985-1018, 2004 | 352 | 2004 |
| Hydrocarbon toxicity: A review LM Tormoehlen, KJ Tekulve, KA Nañagas Clinical toxicology 52 (5), 479-489, 2014 | 245 | 2014 |
| Toxicity associated with carbon monoxide LW Kao, KA Nanagas Clinics in laboratory medicine 26 (1), 99-125, 2006 | 180 | 2006 |
| Organophosphate poisoning DE Rusyniak, KA Nañagas Seminars in neurology 24 (02), 197-204, 2004 | 165 | 2004 |
| Carbon monoxide poisoning LW Kao, KA Nañagas Medical Clinics 89 (6), 1161-1194, 2005 | 146 | 2005 |
| Serotonin syndrome associated with MDPV use: a case report J Mugele, KA Nañagas, LM Tormoehlen Annals of emergency medicine 60 (1), 100-102, 2012 | 80 | 2012 |
| Carbon monoxide toxicity KA Nañagas, SJ Penfound, LW Kao Emergency Medicine Clinics 40 (2), 283-312, 2022 | 44 | 2022 |
| Dimercaptosuccinic acid and Prussian blue in the treatment of acute thallium poisoning in rats DE Rusyniak, LW Kao, KA Nanagas, MA Kirk, RB Furbee, EJ Brizendine, ... Journal of Toxicology: Clinical Toxicology 41 (2), 137-142, 2003 | 27 | 2003 |
| Arsine toxicity treated with red blood cell and plasma exchanges C Danielson, J Houseworth, E Skipworth, D Smith, L McCarthy, ... Transfusion 46 (9), 1576-1579, 2006 | 24 | 2006 |
| Conservative management of elemental mercury retained in the appendix DE Rusyniak, KA Nañagas Clinical Toxicology 46 (9), 831-833, 2008 | 15 | 2008 |
| Deprescribing anticholinergics in primary care older adults: Experience from two models and impact on a continuous measure of exposure NL Campbell, C Pitts, C Corvari, E Kaehr, K Alamer, P Chand, K Nanagas, ... Journal of the American College of Clinical Pharmacy 5 (10), 1039-1047, 2022 | 8 | 2022 |
| Extremely high urine arsenic level after remote seafood ingestion KA Nañagas, LM Tormoehlen American Journal of Therapeutics 21 (3), e75-e77, 2014 | 5 | 2014 |
| “Ghost tablet” husks excreted in feces in large bupropion XL overdose A Overberg, A Purpura, K Nanagas Clinical Toxicology 57 (2), 141-142, 2019 | 4 | 2019 |
| Perceived poisons KA Nañagas, MA Kirk Medical Clinics 89 (6), 1359-1378, 2005 | 4 | 2005 |
| Safety of Physostigmine for Pediatric Antimuscarinic Poisoning S Huber, R Avera, S Penfound, A Overberg, K Nañagas Journal of Medical Toxicology 20 (3), 263-270, 2024 | 1 | 2024 |
| A tale of two botulism cases A Ponce, M Brenner, B Ross, K Nanagas, L Kao, A Overberg CLINICAL TOXICOLOGY 59 (11), 1125-1126, 2021 | 1 | 2021 |
| Class IA Antiarrhythmics: Quinidine, Procainamide, and Disopyramide KA NAÑAGAS, RB FURBEE Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose …, 2007 | 1 | 2007 |
| Conservative management of elemental mercury sequestration in the appendix KA Nanagas, AD O'Connor, ME Potts, DE Rusyniak Journal of Toxicology: Clinical Toxicology 41 (5), 662-663, 2003 | 1 | 2003 |
| In Response to Comment on “Safety of Physostigmine for Pediatric Antimuscarinic Poisoning” K Nañagas, S Huber, R Avera, S Penfound, A Overberg Journal of Medical Toxicology 20 (4), 440-440, 2024 | | 2024 |
| Correction: Safety of Physostigmine for Pediatric Antimuscarinic Poisoning S Huber, R Avera, S Penfound, A Overberg, K Nañagas Journal of Medical Toxicology 20 (3), 338, 2024 | | 2024 |
